Experience the World of Easy NGS

The only true end-to-end NGS solution for oncology biomarker profiling in clinical research: Ion Torrent Genexus System

It's NGS as fast and easy as IHC or PCR

Now every lab can go from biological specimen to report in a single day.

genexus-benefits-graphic

What is truly “end to end” and automated NGS?

Whilst other NGS workflows are advertised as “end to end” and “automated”, we believe that the Ion Torrent™ Genexus™ System and assay menu represents the only true end to end solution in the market. 2 instruments, 1 software and assays, all from one supplier will enable you go from biological specimen to report in as little as 1 day, involving only 20 minutes of hands on time.

What are the benefits of Oncomine NGS Solutions powered by the end-to-end Genexus System?

There is only one supplier of all instrumentation and reagents you require which will simplify your purchasing and technology implementation processes
Only 2 instrument and 1 software will reduce number of validations, SOPs and need for additional expertise
20 min hands on time will allow your technicians to do other work and reduce potential handling errors
Fast turn around time (TAT) will enable you to report complete relevant biomarker profile including results from NGS and IHC or other single gene technologies, fast and at once

Do you want to implement NGS in your lab but think it's too complex?

Not with the Genexus System. Watch video below to learn how bringing NGS in-house is easier than you think.

Ion Torrent Genexus System

Turnkey end-to-end NGS system that automates the specimen to report workflow and delivers results in a single day.

ngs-oncology-workflow-oncomine3

Oncomine Assays for the Genexus System

Oncomine Precision Assay

Oncomine Comprehensive Assay V3

Oncomine TCR Beta-LR Assay

Oncomine Myeloid Research Assay

Oncomine BRCA Assay GX

New Webinars Now Available!

Genexus Webinar Series

Enjoy our on-demand webinar series that gives you a closer look at the new Genexus System and FusionSync technology.

NEW! Introducing the Only True End-to-End NGS Workflow

Discover how the Genexus System enables you to advance from biological specimen to report in as little as one day
Hear from two labs using the Genexus System and the Oncomine Precision Assay explain how and why they decided to use these solutions
Learn about the plan developed by Thermo Fisher Scientific for the IVDR transition

gx-webinar-series-feature-1

NEW! Sharing Experiences From the World of Easy NGS

Learn about the role the Genexus Integrated Sequencer has played in enabling laboratories around the world to provide fast genomic profiling services, even in times of crisis.
Hear from two European labs who implemented NGS for the first time with the Genexus System and the Oncomine Precision Assay

gx-webinar-series-feature-2

A New World of NGS. A New Day for Your Lab

Understand how the Genexus System enables a broad spectrum of labs, even without previous expertise, to provide fast genomic profiling
See the future Genexus System assays pipeline
Hear from Sentara Molecular Pathology Laboratory about their experience with the Genexus System

gx-webinar-series-feature-4

Hear Both Sides of the Fusion Detection Story

Discuss the importance of detecting both novel fusions and known driver genes and partners
Review three different methods of fusion detection in a comparison study performed and presented by Dr. Wei Song
Hear about principle data generated by a FusionSync method developed by Dr. Philip Jermann

gx-webinar-series-feature-5

Genexus News

Read the latest news and user stories about how the Genexus System is advancing precision oncology in our quarterly e-news.

Latest News

The Genexus System and Ion Torrent™ Oncomine™ Dx Target Test are expected to comply with CE mark requirements in 2022

In this issue, we bring you a number of new stories, testimonials, and data from Genexus System users. But first, we want to share that we are working hard on making the Genexus System, and a number of next-generation sequencing (NGS) assays, compliant with the new In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746. Read more.

genexus-news-feature-small-nov21

Genexus Software - It's a New World

Are you worried about NGS bioinformatics? Using different software and requiring an expert to stich it all together? No need anymore! The Genexus Software, one secure, streamlined and easy-to-use NGS analysis software, provides a seamless experience from end to end, starting with entering sample data and finishing with report.

Oncomine Reporter

The Oncomine Reporter delivers clear and concise reports that present all relevant variants with annotated information about targeted therapies, guidelines, and enrollment of ongoing clinical trials.

The report is customizable so that you can tailor it to fit your team's needs.

Learn More About Oncomine Informatics

report-example-new

Watch easy NGS in action

A molecular biology laboratory at the Hospital Universitari Vall d'Hebron performs NGS analysis with the Genexus System.

Molecular Tagging

The Oncomine Precision Assay on the Ion Torrent Genexus System detects low-level variants that are particularly important for liquid biopsy testing. It provides:

Enhanced specificity
Enhanced sensitivity
Artifact detection

Results from Tissue and Plasma Samples

Although tissue samples are still the gold standard for molecular profiling, there exist many limitations.

Tissue can be inaccessible or there may not be enough material to sequence. Further, obtaining a tissue sample is difficult to repeat and not useful for monitoring and the sample may not reflect tumor heterogeneity. Liquid biopsy may be a viable alternative to tissue sequencing, as it is minimally invasive, provides a comprehensive tumor profile, and allows for repeat sampling.

With the Oncomine Precision Assay, you have the flexibility to sequence standard tissue or minimally invasive plasma samples, from one test on a single workflow.

Flexible Financing for Every Lab

Now you don’t have to wait to access the Genexus System. We are committed
to supporting your research by offering a wide range of financial and leasing
programs for even easier adoption of NGS.

NGS Expert Opinions on the Genexus System

Dr. Nicola Normanno and Dr. Philip Jermann on How The Genexus System Can Fit in NGS Experienced or Beginner's Lab. October 2019

See How Easy It Is to Do NGS with the Genexus System

Dr. Nicola Normanno and Dr. Philip Jermann on How The Genexus System Can Fit in NGS Experienced or Beginner's Lab. October 2019

Dr. Nicola Normanno from Naples and Dr. Philip Jermann from Basel, share their opinion on how the new Genexus NGS System can help new laboratories adopt NGS, and also how expert labs can benefit from its speed and simplicity. November 2019

Dr. Jose Costa on His First Impressions and Experience with the Genexus System

Hear from Dr. José Costa of IPATIMUP in Portugal, whose lab was the first to implement the Genexus System. November 2019.

Additional Resources

The Impact of Single-Day NGS. Read The Pathologist Journal Article.

Genexus End-to-End NGS Solutions Flyer

Oncomine Precision Assay on the Ion Torrent Genexus System Infographic

References:

1. Next-Generation Sequencing in 305 Consecutive Patents: Clinical Outcomes and Management Changes; Gregory J. Kubicek, MD., et al., Journal of Clinical Oncology, Aug. 2019.
2. J Clin Oncol. 2019 Apr 20;37(12):992-1000. doi: 10.1200/JCO.18.01042. Epub 2019 Feb 20.
3. Clinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancer; Jason Zhu, et al.; Urologic Cancer: Seminars and Original Investigations, July 2019.
4. Abstract 4889: Comparison of tumor mutational burden using the Ion Oncomine™ TML and FoundationOne™ assays with routine clinical FFPE tissue samples to predict durable clinical benefit in lung cancer and melanoma patients - a multivariate analysis integrating PD-L1 and CD8+ evaluation. Heeke S. et al. DOI: 10.1158/1538-7445.AM2019-4889; July 2019.